Today The MetLife, Inc. (MET) Shares Sold by Jennison Associates LLC

Today The MetLife, Inc. (MET) Shares Sold by Jennison Associates LLC

Jennison Associates LLC reduced its position in shares of MetLife, Inc. (NYSE:MET) by 5.6% during the third quarter, Holdings Channel reports. The fund owned 3,615,254 shares of the company’s stock after selling 213,309 shares during the period. Jennison Associates LLC’s holdings in MetLife were worth $160,626,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. ClariVest Asset Management LLC increased its stake in MetLife by 0.3% in the second quarter. ClariVest Asset Management LLC now owns 2,806 shares of the company’s stock worth $112,000 after buying an additional 8 shares during the last quarter. Keeley Asset Management Corp increased its stake in MetLife by 0.8% in the second quarter. Keeley Asset Management Corp now owns 6,174 shares of the company’s stock worth $246,000 after buying an additional 50 shares during the last quarter. Atlantic Trust Group LLC increased its stake in MetLife by 0.3% in the second quarter. Atlantic Trust Group LLC now owns 22,262 shares of the company’s stock worth $887,000 after buying an additional 67 shares during the last quarter. Wealthfront Inc. increased its stake in MetLife by 0.4% in the second quarter. Wealthfront Inc. now owns 18,140 shares of the company’s stock worth $723,000 after buying an additional 69 shares during the last quarter. Finally, HL Financial Services LLC increased its stake in MetLife by 1.1% in the third quarter. HL Financial Services LLC now owns 6,675 shares of the company’s stock worth $297,000 after buying an additional 71 shares during the last quarter. Hedge funds and other institutional investors own 75.21% of the company’s stock.

Shares of MetLife, Inc. (NYSE:MET) opened at 54.91 on Wednesday. The firm has a market capitalization of $60.35 billion, a PE ratio of 16.87 and a beta of 1.69. MetLife, Inc. has a one year low of $35.00 and a one year high of $58.09. The firm’s 50 day moving average is $54.80 and its 200-day moving average is $47.89.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $1.28 EPS for the quarter, beating the consensus estimate of $1.24 by $0.04. MetLife had a return on equity of 6.99% and a net margin of 5.58%. The company had revenue of $17.70 billion for the quarter, compared to the consensus estimate of $17.03 billion. During the same quarter last year, the company posted $0.62 earnings per share. The company’s revenue for the quarter was down 99.9% compared to the same quarter last year. On average, equities research analysts predict that MetLife, Inc. will post $4.65 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, March 13th. Shareholders of record on Monday, February 6th will be issued a dividend of $0.40 per share. The ex-dividend date is Thursday, February 2nd. This represents a $1.60 annualized dividend and a yield of 2.91%. MetLife’s dividend payout ratio (DPR) is presently 49.23%.

Several equities research analysts have issued reports on MET shares. FBR & Co reiterated a “buy” rating on shares of MetLife in a research note on Thursday, November 3rd. Argus reiterated a “buy” rating and set a $54.00 price objective on shares of MetLife in a research note on Tuesday, November 8th. Deutsche Bank AG reiterated a “hold” rating and set a $44.00 price objective on shares of MetLife in a research note on Saturday, October 8th. TheStreet upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Friday, October 28th. Finally, J P Morgan Chase & Co reiterated a “buy” rating and set a $51.00 price objective on shares of MetLife in a research note on Friday, November 4th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. MetLife has an average rating of “Buy” and a consensus target price of $53.31.

In other news, EVP Maria R. Morris sold 2,200 shares of the firm’s stock in a transaction on Tuesday, November 1st. The shares were sold at an average price of $47.33, for a total value of $104,126.00. Following the sale, the executive vice president now owns 109,809 shares in the company, valued at $5,197,259.97. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Frans Hijkoop sold 56,250 shares of the firm’s stock in a transaction on Wednesday, November 9th. The stock was sold at an average price of $51.48, for a total transaction of $2,895,750.00. Following the completion of the sale, the executive vice president now owns 111,813 shares in the company, valued at approximately $5,756,133.24. The disclosure for this sale can be found here. In the last quarter, insiders have sold 97,083 shares of company stock worth $5,126,315. Corporate insiders own 0.27% of the company’s stock.

About MetLife

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Related posts

Leave a Comment